Skip to main content
OpenTrials
Completed

NCT Number: NCT07617857

Whole-Body Cryotherapy and Isokinetic Performance After Exercise-Induced Fatigue

This randomized crossover study investigated the effects of whole-body cryotherapy (WBC) on isokinetic knee performance following running-induced fatigue in physically active healthy male university students. Participants completed two recovery conditions, WBC and passive rest, on separate days following a standardized treadmill fatigue protocol. Knee extension and flexion strength were assessed using an isokinetic dynamometer at angular velocities of 60°/s and 240°/s. In addition, blood pressure, heart rate, oxygen saturation, and perceived fatigue responses were monitored throughout the recovery period. The study aimed to determine whether WBC improves post-exercise recovery and lower-extremity muscle performance compared with passive rest.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Istanbul University

Istanbul, 34000, Turkey (Türkiye)

About this study

This study was designed to investigate the effects of whole-body cryotherapy (WBC) on recovery and isokinetic muscle performance following exercise-induced fatigue in physically active healthy male university students. Exercise-induced fatigue is associated with reduced muscle force production, impaired performance, and increased injury risk. Various recovery strategies have been used to minimize these negative effects, and WBC has gained increasing attention in sports medicine because of its potential physiological and neuromuscular recovery benefits.

The study used a randomized within-subject crossover design in which participants completed two recovery conditions, WBC and passive rest, on separate days following a standardized treadmill-based fatigue protocol. During the WBC condition, participants were exposed to a two-stage cryogenic chamber consisting of an adaptation chamber at -30°C followed by a main chamber at -85°C. Passive rest sessions were performed under the same laboratory conditions without cryotherapy exposure.

Primary outcome measures included isokinetic knee extension and flexion performance assessed at angular velocities of 60°/s and 240°/s using an isokinetic dynamometer. Peak torque and body mass-normalized peak torque values were analyzed for both dominant and non-dominant lower extremities. Secondary outcome measures included systolic and diastolic blood pressure, heart rate, oxygen saturation, and perceived fatigue responses measured throughout the recovery period.

The aim of the study was to determine whether WBC provides superior recovery effects compared with passive rest following running-induced acute fatigue.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy male participants aged 18-30 years with no exercise limitation
  • No history of knee or lower-extremity injury requiring physiotherapy or surgical intervention
  • No current lower-extremity pain
  • No limitation in lower-extremity range of motion
  • No chronic disease
  • No mental or psychological disorder

Exclusion criteria

  • Presence of cardiovascular disease
  • Presence of respiratory disease
  • History of cold allergy
  • Presence of a tumor-related disease
  • Presence of a viral or bacterial infection
  • Diagnosis of Raynaud's disease
  • Presence of claustrophobia

Treatment and study plan

Whole-Body Cryotherapy

Procedure

Participants underwent whole-body cryotherapy following a standardized running-induced fatigue protocol. The intervention was performed in a two-stage cryogenic chamber consisting of a 30-second adaptation phase at -30°C followed by a 3-minute exposure at -85°C.

Primary outcomes

  1. Peak Torque During Knee Extension and Flexion

    Time frame: Immediately after the 30-minute recovery period

    Assessment of isokinetic knee extension and flexion peak torque at 60°/s and 240°/s following whole-body cryotherapy and passive rest recovery conditions.

  2. Peak Torque Normalized to Body Mass

    Time frame: Immediately after the 30-minute recovery period

    Assessment of body mass-normalized peak torque values during isokinetic knee extension and flexion testing at 60°/s and 240°/s.

Secondary outcomes

  1. Heart Rate

    Time frame: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period

    Assessment of heart rate responses throughout the recovery period following exercise-induced fatigue.

  2. Blood Pressure

    Time frame: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period

    Assessment of systolic and diastolic blood pressure responses throughout the recovery period.

  3. Oxygen Saturation

    Time frame: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period

    Assessment of peripheral oxygen saturation during the recovery period.

  4. Perceived Fatigue

    Time frame: Immediately after exercise, 5 minutes, and 10 minutes after exercise

    Assessment of perceived fatigue using the Borg Rating of Perceived Exertion (RPE) Scale (6-20 points). Scores range from 6 (no exertion) to 20 (maximal exertion), with higher scores indicating greater perceived fatigue and exertion.

Sponsors and collaborators

Lead sponsor

Biruni University

Other

Registry information

Official study title

Effect of Whole-Body Cryotherapy on Isokinetic Performance After Exercise-Induced Fatigue

Acronym: WBC-ISO

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 1, 2026
Registry last updated
Jun 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.